AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
3.890
+0.500 (14.75%)
At close: Mar 9, 2026, 4:00 PM EDT
3.860
-0.030 (-0.77%)
After-hours: Mar 9, 2026, 6:30 PM EDT
AtaiBeckley Market Cap
AtaiBeckley has a market cap or net worth of $1.41 billion as of March 9, 2026. Its market cap has increased by 257.02% in one year.
Market Cap
1.41B
Enterprise Value
1.30B
1-Year Change
257.02%
Ranking
Category
Stock Price
$3.89
Market Cap Chart
Since the IPO on June 18, 2021, AtaiBeckley's market cap has decreased from $2.29B to $1.41B, a decrease of -38.26%. That is a compound annual growth rate of -9.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.23B | -17.11% |
| Dec 31, 2025 | 1.49B | 565.59% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corvus Pharmaceuticals | 1.32B |
| Immatics | 1.32B |
| EyePoint | 1.31B |
| Savara | 1.30B |
| MoonLake Immunotherapeutics | 1.30B |
| Septerna | 1.29B |
| Taysha Gene Therapies | 1.25B |
| DBV Technologies | 1.21B |